Abstract: The present invention belongs to the field of pharmaceutical technology, specifically disclosing a class of thienopyrimidine compounds with the general formula I, theirs stereoisomeric forms, stereoisomeric mixtures and pharmaceutically acceptable salts, hydrates and solvents. Also including theirs polycrystalline and eutectic, prodrugs and derivatives with same biologically functional, methods for their preparation, and compositions containing one or more of these compounds in the drugs application of treatment and prevention of human immunodeficiency virus (HIV).

Abstract: The invention relates to pyrido[2,3-d]pyrimidine compound WB3 and its preparation method and application. The structure of WB3 is as follows, and the invention also relates to a pharmaceutical composition of WB3. Moreover, the invention also provides applications of the WB3 in the preparation of drugs for the treatment and prevention of HIV.

Abstract: The present invention belongs to the field of pharmaceutical technology, specifically disclosing thiazolopyrimidine compounds with the general formulas I and II. Also including theirs polycrystalline and eutectic, prodrugs and derivatives with same biologically functional, methods for their preparation, and compositions containing one or more of these compounds in the drugs application of treatment and prevention of human immunodeficiency virus.

Abstract: The present invention belongs to the field of pharmaceutical technology, specifically disclosing five-membered non-aromatic pyrimidines compounds with the general formulas I. Also including theirs polycrystalline and eutectic, prodrugs and derivatives with same biologically functional, methods for their preparation, and compositions containing one or more of these compounds in the drugs application of treatment and prevention of human immunodeficiency virus.

Abstract: A battery has a cathode, an anode and an electrolyte, with the cathode having a cathode current collector and a cathode material. The cathode material has a cathode active material, which is capable of reversibly intercalating and deintercalating first metal ions. The electrolyte has a solvent capable of dissolving the first metal ions and second metal ions that can be reduced to a metal during a charge cycle and be oxidized from the metal to the dissolved second metal ions during a discharge cycle. The cathode current collector has an electrochemically inert carrier and graphite. The carrier is wrapped by the graphite. The cathode current collector provided has good corrosion resistance and the battery has a long floating charge life and a low cost.

Abstract: The present invention belongs to the field of pharmaceutical technology, specifically disclosing thiazolopyrimidine compounds with the general formulas I and II. Also including theirs polycrystalline and eutectic, prodrugs and derivatives with same biologically functional, methods for their preparation, and compositions containing one or more of these compounds in the drugs application of treatment and prevention of human immunodeficiency virus.

Abstract: The present invention belongs to the field of pharmaceutical technology, specifically disclosing five-membered non-aromatic pyrimidines compounds with the general formulas I. Also including theirs polycrystalline and eutectic, prodrugs and derivatives with same biologically functional, methods for their preparation, and compositions containing one or more of these compounds in the drugs application of treatment and prevention of human immunodeficiency virus.

Abstract: The invention relates the tetrahydrothiopyranopyrimidine derivatives, the preparation, and the use thereof. The invention contained tetrahydrothiopyranopyrimidine derivatives, and pharmaceutical acceptable salt and prodrug with the formula I or II. Also described here are preparation of tetrahydrothiopyranopyrimidine derivatives, pharmaceutical compositions comprising these compounds as therapy and prevention for HIV.

Abstract: The invention relates the tetrahydrothiopyranopyrimidine derivatives, the preparation, and the use thereof. The invention contained tetrahydrothiopyranopyrimidine derivatives, and pharmaceutical acceptable salt and prodrug with the formula I or II. Also described here are preparation of tetrahydrothiopyranopyrimidine derivatives, pharmaceutical compositions comprising these compounds as therapy and prevention for HIV.

Abstract: It relates to the imidazopyridine thioglycolic acid derivatives, the preparation, and use thereof. The invention contained imidazopyridine thioglycolic acid derivatives with the formula I or II or III. Also described here are preparation of imidazopyridine thioglycolic acid derivatives, pharmaceutical compositions comprising these compounds as therapy and prevention for gout.

Abstract: It relates to the imidazopyridine thioglycolic acid derivatives, the preparation, and use thereof. The invention contained imidazopyridine thioglycolic acid derivatives with the formula I or II or III. Also described here are preparation of imidazopyridine thioglycolic acid derivatives, pharmaceutical compositions comprising these compounds as therapy and prevention for gout.

Abstract: A battery has a cathode, an anode and an electrolyte, with the cathode having a cathode current collector and a cathode material. The cathode material has a cathode active material, which is capable of reversibly intercalating and deintercalating first metal ions. The electrolyte has a solvent capable of dissolving the first metal ions and second metal ions that can be reduced to a metal during a charge cycle and be oxidized from the metal to the dissolved second metal ions during a discharge cycle. The cathode current collector has an electrochemically inert carrier and graphite. The carrier is wrapped by the graphite. The cathode current collector provided has good corrosion resistance and the battery has a long floating charge life and a low cost.